Efficiency of tofacitinib in refractory interstitial lung disease among anti-MDA5 positive juvenile dermatomyositis patientsYuan Xue, Xiaohua Tan, Chao Li et al.|Annals of the Rheumatic Diseases|2023Cited by 15
Identification of 4 subgroups in juvenile dermatomyositis by principal component analysis-based cluster analysisJunmei Zhang, Caifeng Li, Yuan Xue et al.|Clinical and Experimental Rheumatology|2022Cited by 10
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter StudyXuanyi Liu, Caifeng Li, Junmei Zhang et al.|The Journal of Rheumatology|2024Cited by 0